Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adverse Events Following Immunization With mRNA and Viral Vector Vaccines in Individuals With Previous Severe Acute Respiratory Syndrome Coronavirus 2 Infection From the Canadian National Vaccine Safety Network.
Bettinger JA, Irvine MA, Shulha HP, Valiquette L, Muller MP, Vanderkooi OG, Kellner JD, Top KA, Sadarangani M, McGeer A, Isenor JE, Marty K, Soe P, De Serres G; Canadian Immunization Research Network. Bettinger JA, et al. Among authors: marty k. Clin Infect Dis. 2023 Mar 21;76(6):1088-1102. doi: 10.1093/cid/ciac852. Clin Infect Dis. 2023. PMID: 36310514 Free PMC article.
Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study.
Langley JM, MacDougall DM, Halperin BA, Swain A, Halperin SA, Top KA, McNeil SA, MacKinnon-Cameron D, Marty K, De Serres G, Dubé E, Bettinger JA. Langley JM, et al. Among authors: marty k. Vaccine. 2016 Jul 25;34(34):4046-9. doi: 10.1016/j.vaccine.2016.06.025. Epub 2016 Jun 11. Vaccine. 2016. PMID: 27302338
The Canadian National Vaccine Safety Network: surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada.
Bettinger JA, Sadarangani M, De Serres G, Valiquette L, Vanderkooi OG, Kellner JD, Muller MP, Top KA, Isenor JE, McGeer A, Marty K; Canadian Immunization Research Network. Bettinger JA, et al. Among authors: marty k. BMJ Open. 2022 Jan 20;12(1):e051254. doi: 10.1136/bmjopen-2021-051254. BMJ Open. 2022. PMID: 35058258 Free PMC article.
Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study.
Sadarangani M, Soe P, Shulha HP, Valiquette L, Vanderkooi OG, Kellner JD, Muller MP, Top KA, Isenor JE, McGeer A, Irvine M, De Serres G, Marty K, Bettinger JA; Canadian Immunization Research Network. Sadarangani M, et al. Among authors: marty k. Lancet Infect Dis. 2022 Nov;22(11):1553-1564. doi: 10.1016/S1473-3099(22)00426-1. Epub 2022 Aug 11. Lancet Infect Dis. 2022. PMID: 35964614 Free PMC article.
mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network.
Soe P, Wong H, Naus M, Muller MP, Vanderkooi OG, Kellner JD, Top KA, Sadarangani M, Isenor JE, Marty K, De Serres G, Valiquette L, McGeer A, Bettinger JA; Canadian Immunization Research Network. Soe P, et al. Among authors: marty k. Vaccine. 2024 Jul 11;42(18):3819-3829. doi: 10.1016/j.vaccine.2024.04.096. Epub 2024 May 6. Vaccine. 2024. PMID: 38714447 Free article.
Impact of recruitment strategies on individual participation practices in the Canadian National Vaccine Safety Network: prospective cohort study.
Soe P, Sadarangani M, Naus M, Muller MP, Vanderkooi OG, Kellner JD, Top KA, Wong H, Isenor JE, Marty K, De Serres G, Valiquette L, McGeer A, Bettinger JA; Canadian Immunization Research Network. Soe P, et al. Among authors: marty k. Front Public Health. 2024 Aug 12;12:1385426. doi: 10.3389/fpubh.2024.1385426. eCollection 2024. Front Public Health. 2024. PMID: 39188790 Free PMC article.
Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study.
Top KA, Shulha HP, Muller MP, Valiquette L, Vanderkooi OG, Kellner JD, Sadarangani M, Irvine MA, McGeer A, Isenor JE, Marty K, Soe P, De Serres G, Bettinger JA; Canadian Immunization Research Network Investigators. Top KA, et al. Among authors: marty k. Vaccine. 2024 Dec 2;42(26):126445. doi: 10.1016/j.vaccine.2024.126445. Epub 2024 Oct 16. Vaccine. 2024. PMID: 39413493 Free article.
mRNA COVID-19 vaccine safety among children and adolescents: a Canadian National Vaccine Safety Network cohort study.
Soe P, Vanderkooi OG, Sadarangani M, Naus M, Muller MP, Kellner JD, Top KA, Wong H, Isenor JE, Marty K, Shulha HP, De Serres G, Valiquette L, McGeer A, Bettinger JA. Soe P, et al. Among authors: marty k. Lancet Reg Health Am. 2024 Nov 27;40:100949. doi: 10.1016/j.lana.2024.100949. eCollection 2024 Dec. Lancet Reg Health Am. 2024. PMID: 39659558 Free PMC article.
Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial.
Bota AB, Bettinger JA, Sarfo-Mensah S, Lopez J, Smith DP, Atkinson KM, Bell C, Marty K, Serhan M, Zhu DT, McCarthy AE, Wilson K. Bota AB, et al. Among authors: marty k. JMIR Public Health Surveill. 2023 May 8;9:e39700. doi: 10.2196/39700. JMIR Public Health Surveill. 2023. PMID: 37155240 Free PMC article. Clinical Trial.
31 results